Sandoz Inc Drug Patent Portfolio

Sandoz Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

More affordable obesity treatments may be available in Canada this summer, according to Health ... - Radio-Canada

08 Jan, 2026

More affordable obesity treatments may be available in Canada this summer, according to Health Canada... - CBC

06 Jan, 2026

Starting next week, companies will be allowed to produce generic versions of Ozempic, but availability may take some time.

03 Jan, 2026

Zacks Industry Analysis Focuses on Sandoz, Teva Pharmaceuticals, and Dr. Reddy's

09 Dec, 2025